Subscribe
Subscribe today to receive CGD’s latest newsletters and topic updates.
All Commentary
Filters:
Topics
Facet Toggle
Content Type
Facet Toggle
Time Frame
Facet Toggle
Blog Post
February 20, 2024
In a new note, I suggest there’s little evidence that aid (official development assistance, or ODA) spent on climate mitigation is actually reducing emissions. That’s not to say the finance is wasted: much will have been spent on projects with considerable development impact and some, surely, reduce...
Blog Post
February 19, 2024
One of the few silver linings from Brexit for the UK has been the increase in non-EU migration. But this has led to renewed concerns about a “brain drain”, the notion that the exodus of skilled workers from poorer countries will leave them unable to meet their own development goals. Yet these concer...
Blog Post
February 08, 2024
What’s the best way for a think tank fellow to demonstrate they’re washed up? Say there’s no need for new policy. And yet…
This year, donors will negotiate the replenishment of the World Bank’s soft lending arm, IDA. World Bank president Ajay Banga wants to the replenishment amount to be the bigges...
Blog Post
February 08, 2024
With several replenishment campaigns set for 2024-2025, a fundraising pileup is on the horizon. Close to a dozen major development funds—including the World Bank’s International Development Association (IDA), thematic funds like Gavi, and new entities like the Loss and Damage Fund—could aim to raise...
Blog Post
February 06, 2024
The World Bank’s Independent Evaluation Group has just issued a “Focused Assessment” of the IDA Private Sector Window, looking at the PSW’s first five years of operation. The PSW, launched in 2018, uses $5.6 billion of World Bank IDA financing to subsidize IFC and MIGA investments in the private sec...
Blog Post
January 30, 2024
Since its launch in 2000, Gavi, the Vaccine Alliance, has leveraged three primary levers to expand equitable vaccine access in lower-income countries. First, Gavi supports introductions of new and underused vaccines. Second, Gavi helps scale equitable immunization coverage rates. Third, Gavi uses an...